questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Sirtuines
Sirtuine-1
Sirtuine-1 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Complement C3-C5 Convertases
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sirtuine-1 : Questions médicales les plus fréquentes",
"headline": "Sirtuine-1 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sirtuine-1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-13",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sirtuine-1"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sirtuines",
"url": "https://questionsmedicales.fr/mesh/D037761",
"about": {
"@type": "MedicalCondition",
"name": "Sirtuines",
"code": {
"@type": "MedicalCode",
"code": "D037761",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.900"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Sirtuine-1",
"alternateName": "Sirtuin 1",
"code": {
"@type": "MedicalCode",
"code": "D056564",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Giulia Bononi",
"url": "https://questionsmedicales.fr/author/Giulia%20Bononi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it."
}
},
{
"@type": "Person",
"name": "Valentina Citi",
"url": "https://questionsmedicales.fr/author/Valentina%20Citi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it."
}
},
{
"@type": "Person",
"name": "Alma Martelli",
"url": "https://questionsmedicales.fr/author/Alma%20Martelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it."
}
},
{
"@type": "Person",
"name": "Giulio Poli",
"url": "https://questionsmedicales.fr/author/Giulio%20Poli",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it."
}
},
{
"@type": "Person",
"name": "Tiziano Tuccinardi",
"url": "https://questionsmedicales.fr/author/Tiziano%20Tuccinardi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacy, University of Pisa Via Bonanno 6 56126 Pisa Italy giulia.bononi@farm.unipi.it valentina.citi@unipi.it alma.martelli@unipi.it giulio.poli@unipi.it tiziano.tuccinardi@unipi.it carlotta.granchi@unipi.it lara.testai@unipi.it vincenzo.calderone@unipi.it filippo.minutolo@unipi.it."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies.",
"datePublished": "2023-06-23",
"url": "https://questionsmedicales.fr/article/37356719",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbc.2023.104956"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BPα as a Biomarker to Predict Clopidogrel Resistance.",
"datePublished": "2024-01-23",
"url": "https://questionsmedicales.fr/article/38261250",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40291-023-00691-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Cell-Based Assay to Measure the Activity of the Complement Convertases.",
"datePublished": "2024-05-04",
"url": "https://questionsmedicales.fr/article/39081762",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ekir.2024.04.058"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Role of Complement Component C3 in Protection Against",
"datePublished": "2024-02-06",
"url": "https://questionsmedicales.fr/article/38324102",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1089/dna.2023.0445"
}
},
{
"@type": "ScholarlyArticle",
"name": "Methanol bioconversion into C3, C4, and C5 platform chemicals by the yeast Ogataea polymorpha.",
"datePublished": "2024-01-03",
"url": "https://questionsmedicales.fr/article/38172830",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12934-023-02283-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sirtuines",
"item": "https://questionsmedicales.fr/mesh/D037761"
},
{
"@type": "ListItem",
"position": 6,
"name": "Sirtuine-1",
"item": "https://questionsmedicales.fr/mesh/D056564"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sirtuine-1 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sirtuine-1",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sirtuine-1",
"description": "Comment évaluer le niveau de Sirtuine-1 ?\nQuels tests sont utilisés pour la Sirtuine-1 ?\nY a-t-il des biomarqueurs associés à Sirtuine-1 ?\nLa génétique influence-t-elle Sirtuine-1 ?\nPeut-on mesurer Sirtuine-1 dans les tissus ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Complement+C3-C5+Convertases&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sirtuine-1",
"description": "Quels symptômes sont liés à une faible Sirtuine-1 ?\nLa Sirtuine-1 affecte-t-elle le vieillissement ?\nQuels effets sur la santé mentale ?\nY a-t-il des symptômes de maladies liées à Sirtuine-1 ?\nSirtuine-1 influence-t-elle l'énergie cellulaire ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Complement+C3-C5+Convertases&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sirtuine-1",
"description": "Comment prévenir la baisse de Sirtuine-1 ?\nLe stress affecte-t-il Sirtuine-1 ?\nY a-t-il des habitudes à éviter ?\nLe sommeil influence-t-il Sirtuine-1 ?\nDes suppléments pour Sirtuine-1 ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Complement+C3-C5+Convertases&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sirtuine-1",
"description": "Quels traitements augmentent Sirtuine-1 ?\nY a-t-il des médicaments ciblant Sirtuine-1 ?\nComment la nutrition affecte-t-elle Sirtuine-1 ?\nL'exercice physique influence-t-il Sirtuine-1 ?\nDes thérapies géniques pour Sirtuine-1 ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Complement+C3-C5+Convertases&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sirtuine-1",
"description": "Quelles complications sont liées à une faible Sirtuine-1 ?\nSirtuine-1 et maladies cardiovasculaires ?\nY a-t-il un lien avec le diabète ?\nSirtuine-1 et cancer ?\nComplications neurologiques liées à Sirtuine-1 ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Complement+C3-C5+Convertases&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sirtuine-1",
"description": "Quels facteurs augmentent le risque de faible Sirtuine-1 ?\nL'alimentation influence-t-elle Sirtuine-1 ?\nLe mode de vie sédentaire affecte-t-il Sirtuine-1 ?\nLe tabagisme impacte-t-il Sirtuine-1 ?\nLe stress oxydatif influence-t-il Sirtuine-1 ?",
"url": "https://questionsmedicales.fr/mesh/D056564?mesh_terms=Complement+C3-C5+Convertases&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer le niveau de Sirtuine-1 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le niveau de Sirtuine-1 peut être mesuré par des tests sanguins ou des biopsies tissulaires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la Sirtuine-1 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des analyses protéomiques sont utilisés pour évaluer Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés à Sirtuine-1 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biomarqueurs comme les niveaux de NAD+ peuvent être associés à Sirtuine-1."
}
},
{
"@type": "Question",
"name": "La génétique influence-t-elle Sirtuine-1 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des variations génétiques peuvent affecter l'expression de Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer Sirtuine-1 dans les tissus ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Sirtuine-1 peut être mesurée dans des échantillons de tissus par immunohistochimie."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une faible Sirtuine-1 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une faible Sirtuine-1 peut être associée à des troubles métaboliques et à l'inflammation."
}
},
{
"@type": "Question",
"name": "La Sirtuine-1 affecte-t-elle le vieillissement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Sirtuine-1 est impliquée dans la régulation du vieillissement cellulaire et de la longévité."
}
},
{
"@type": "Question",
"name": "Quels effets sur la santé mentale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de Sirtuine-1 peuvent influencer l'humeur et la cognition."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes de maladies liées à Sirtuine-1 ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète et les maladies neurodégénératives sont liées à Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Sirtuine-1 influence-t-elle l'énergie cellulaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Sirtuine-1 joue un rôle clé dans la régulation de l'énergie cellulaire et du métabolisme."
}
},
{
"@type": "Question",
"name": "Comment prévenir la baisse de Sirtuine-1 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain avec une bonne nutrition et de l'exercice aide à prévenir la baisse."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il Sirtuine-1 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut réduire l'expression de Sirtuine-1 dans les cellules."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes à éviter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et une alimentation riche en sucres peut aider à maintenir Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Le sommeil influence-t-il Sirtuine-1 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un sommeil de qualité est essentiel pour maintenir des niveaux optimaux de Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Des suppléments pour Sirtuine-1 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments comme le resvératrol peuvent être bénéfiques pour soutenir Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Quels traitements augmentent Sirtuine-1 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements comme le resvératrol et l'exercice physique peuvent augmenter Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments ciblant Sirtuine-1 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments expérimentaux visent à moduler l'activité de Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Comment la nutrition affecte-t-elle Sirtuine-1 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en polyphénols peut stimuler l'expression de Sirtuine-1."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il Sirtuine-1 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier est connu pour augmenter les niveaux de Sirtuine-1 dans le corps."
}
},
{
"@type": "Question",
"name": "Des thérapies géniques pour Sirtuine-1 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur les thérapies géniques pour moduler Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à une faible Sirtuine-1 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une faible Sirtuine-1 est liée à des maladies métaboliques et à des troubles neurodégénératifs."
}
},
{
"@type": "Question",
"name": "Sirtuine-1 et maladies cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux bas de Sirtuine-1 peuvent augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec le diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une faible Sirtuine-1 est associée à une résistance à l'insuline et au diabète de type 2."
}
},
{
"@type": "Question",
"name": "Sirtuine-1 et cancer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que Sirtuine-1 pourrait jouer un rôle dans la progression de certains cancers."
}
},
{
"@type": "Question",
"name": "Complications neurologiques liées à Sirtuine-1 ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une dysrégulation de Sirtuine-1 est liée à des maladies comme Alzheimer et Parkinson."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de faible Sirtuine-1 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le vieillissement et le stress chronique augmentent le risque de faible Sirtuine-1."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle Sirtuine-1 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation pauvre en nutriments peut réduire l'expression de Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire affecte-t-il Sirtuine-1 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire est un facteur de risque pour une faible Sirtuine-1."
}
},
{
"@type": "Question",
"name": "Le tabagisme impacte-t-il Sirtuine-1 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à une diminution des niveaux de Sirtuine-1 dans l'organisme."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif influence-t-il Sirtuine-1 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut réduire l'activité de Sirtuine-1 et affecter la santé cellulaire."
}
}
]
}
]
}
The human complement system plays a crucial role in immune defense. However, its erroneous activation contributes to many serious inflammatory diseases. Since most unwanted complement effector functio...
The complement system plays a dual role in the body, either as a first-line defense barrier when balanced between activation and inhibition or as a potential driver of complement-associated injury or ...
The complement system serves as a crucial defense mechanism against invading pathogens; however, dysregulation of this system can result in harmful consequences. Central to the complement cascade are ...
In this study, we propose a novel assay for the functional evaluation of these complexes. Our approach leverages a widely available human lymphoma cell line, which when sensitized with antibodies, tri...
The assay detects recombinant gain-of-function (GoF) components of both convertase types within human serum or plasma. Furthermore, we demonstrate the assay's practical utility in analyzing nephrologi...
We provided a proof-of-concept of a new assay that detects convertase overactivity in individuals carrying variants of both pathogenic character or those of unknown significance in ubiquitous compleme...
The complement system is a family of proteins that facilitate immune resistance by attacking microbes to decrease pathogen burden. As a result, deficiencies of certain complement proteins result in re...
One carbon (C1) molecules such as methanol have the potential to become sustainable feedstocks for biotechnological processes, as they can be derived from CO...
We successfully engineered O. polymorpha for the production of all three molecules and demonstrated their production using methanol as carbon source. We showed that the metabolism of O. polymorpha is ...
These findings highlight how O. polymorpha has the potential to be applied as a versatile cell factory and contribute to the limited knowledge on how methylotrophic yeasts can be used for the producti...
The liver-derived circulating in peripheral blood and intrinsic cell-expressed complement known as complosome orchestrate the trafficking of hematopoietic stem/progenitor cells (HSPCs) both during pha...
An excessively activated or dysregulated complement system has been proven to be a vital contributor to the pathogenesis of periodontitis. It has been previously hypothesized that inhibiting the activ...
In our primary analysis, we used 26 independent 'cis' single nucleotide polymorphisms as IVs from the vicinity of the encoding locus of C5 that are associated with plasma C5 levels. In a secondary ana...
In our primary approach, inhibiting C5 reduced the risk of periodontitis (Odds ratio 0.89 per 1 standard deviation reduction in C5; 95% confidence Interval 0.80-0.98,...
The findings from our study suggest that C5 inhibition may reduce the risk of periodontitis, prioritizing C5 inhibitors as a potential adjunctive therapeutic intervention in this disease....
Coronary heart disease leading to myocardial ischemia is a major cause of heart failure. A hallmark of heart failure is myocardial fibrosis. Using a murine model of myocardial ischemia/reperfusion inj...
The thrombin generation assay (TGA) evaluates the potential of plasma to generate thrombin over time, providing a global picture of an individual's hemostatic balance....
This study aimed to identify novel biological determinants of thrombin generation using a multi-omics approach....
Associations between TGA parameters and plasma levels of 377 antibodies targeting 236 candidate proteins for cardiovascular risk were tested using multiple linear regression analysis in 770 individual...
Eighteen proteins were associated (p<1.33x10-4) with at least three TGA parameters in MARTHA, among which 13 demonstrated a similar pattern of associations in EFS-AM. Complement proteins C5 and C9 had...
This study identified complement proteins C5 and C9 as potential determinants of thrombin generation. Further studies are warranted to establish causality and elucidate the underlying mechanisms....
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease characterized by damage to the alveolar epithelium, leading to fibrosis and excessive accumulation of extracellul...